The antimalarial ferroquine is an inhibitor of hepatitis C virus.
about
Entry inhibitors: New advances in HCV treatmentHost-Targeting Agents to Prevent and Cure Hepatitis C Virus InfectionIdentification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoproteinHepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection.Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus.Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity.New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C VirusHow hepatitis C virus invades hepatocytes: the mystery of viral entryNew horizons in hepatitis C antiviral therapy with direct-acting antivirals.Modulation of autophagy for the treatment of liver diseases.Chloroquine-containing compounds: a patent review (2010 - 2014).Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly"Too little, too late?" Will inhibitors of the hepatitis C virus p7 ion channel ever be used in the clinic?Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseasesA Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner.Anti-hepatitis C virus potency of a new autophagy inhibitor using human liver slices model.
P2860
Q26770817-59D6DA1E-8D1C-4A6B-8771-3B436918875CQ26779128-71F5EFED-CC1D-4F66-90D0-5AB088BBC7BAQ27333881-CEACD4EC-6E35-4D7F-8F70-8A80B4D39785Q30386551-C6934488-EA1C-48EE-97AC-3274B7810C6FQ34470890-BBC892FA-A49B-4849-89DE-33F3929BD8FAQ34936072-7782E6DA-2A5B-4218-982A-A264F41D3797Q35911482-4E229702-6A13-4445-8A98-AC31D8499B8BQ35914270-5F05595C-37D9-4AF4-89C3-3655AD0F3FBFQ37252935-18191EC3-D832-4137-B7C0-29CD7D48F3BCQ37682499-C634C2FA-628E-441A-8CD3-A37E193E2657Q38087250-56A9EC39-B2C9-4B0F-BD75-DD964FBBADA4Q38205866-175213D4-AB40-4BFB-8BC9-7421E349F368Q38503439-CB400CAA-9A2B-4DEF-864F-B256953BDB97Q38717202-D81A17E5-56D6-421E-A047-8E61B3E49FF7Q39077941-664BF809-6003-446A-8272-A06C287079A1Q39360987-B879CAF0-E7A5-4800-B49C-685FB6F0FFA5Q40278524-EDBEDCA4-E8FF-4D97-BF5C-2DC54401C88FQ40593359-4168D89A-99E5-4452-988F-E765EC6B0920
P2860
The antimalarial ferroquine is an inhibitor of hepatitis C virus.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The antimalarial ferroquine is an inhibitor of hepatitis C virus.
@en
The antimalarial ferroquine is an inhibitor of hepatitis C virus.
@nl
type
label
The antimalarial ferroquine is an inhibitor of hepatitis C virus.
@en
The antimalarial ferroquine is an inhibitor of hepatitis C virus.
@nl
prefLabel
The antimalarial ferroquine is an inhibitor of hepatitis C virus.
@en
The antimalarial ferroquine is an inhibitor of hepatitis C virus.
@nl
P2093
P2860
P50
P356
P1433
P1476
The antimalarial ferroquine is an inhibitor of hepatitis C virus
@en
P2093
Catherine François
Czeslaw Wychowski
Florian Douam
Gilles Duverlie
Lucie Fénéant
Noémie Calland
Thibaut Vausselin
Véronique Descamps
P2860
P356
10.1002/HEP.26273
P407
P50
P577
2013-05-14T00:00:00Z